Trump announces trade deal with EU following months of negotiations
SCOTTSDALE, AZ - Axon Enterprise, Inc. (NASDAQ:AXON), a leader in the development of law enforcement technology with a market capitalization of $37.73 billion, has released its financial results for the fourth quarter and full year ended December 31, 2024. The company, which has maintained impressive gross profit margins of nearly 60% and achieved revenue growth of 32% over the last twelve months, disclosed its results in a shareholder letter dated today, as part of an 8-K filing with the Securities and Exchange Commission. According to InvestingPro, 13 analysts have recently revised their earnings expectations upward for the upcoming period.
For the three months concluding the year, Axon reported a series of financial metrics that reflect the company’s performance. While the specific figures were not detailed in the summary provided, InvestingPro analysis reveals the company maintains strong financial health with more cash than debt on its balance sheet and liquid assets exceeding short-term obligations. The shareholder letter, which includes comprehensive data and analysis, is attached as Exhibit 99.1 to the 8-K filing. InvestingPro subscribers have access to over 20 additional key insights about Axon’s financial position and growth prospects.
The company, formerly known as TASER International Inc., has its headquarters in Scottsdale, Arizona, and is incorporated in Delaware. Axon’s business address and contact information remain unchanged, as per the latest SEC filing.
Axon’s common stock is listed on The NASDAQ Stock Market LLC under the ticker symbol AXON. The filing confirms that the information contained in the report, including the results of operations and financial condition, is furnished and not filed. Therefore, it is not subject to the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended.
The report does not indicate whether Axon has provided any forward-looking statements regarding its future performance or market conditions. As with all financial disclosures, the information provided by Axon should be interpreted in the context of the full shareholder letter and the company’s historical performance.
Investors and interested parties can refer to the full text of the shareholder letter for a detailed account of Axon’s financial results. The company’s operations focus on the manufacturing sector, specifically in the ordnance and accessories segment, excluding vehicles and guided missiles.
This news summary is based on a press release statement and provides an overview of the key information released by Axon Enterprise, Inc. regarding its financial results for the past quarter and year. For a deeper understanding of Axon’s financial position and growth potential, investors can access comprehensive analysis and Fair Value estimates through InvestingPro’s detailed research reports, available for over 1,400 US stocks.
In other recent news, Axon Enterprise has been the subject of various analyst reports highlighting its financial and strategic developments. Goldman Sachs recently raised its price target for Axon to $700, maintaining a Buy rating, citing expectations of a strong fourth-quarter EBITDA of $148 million for 2024, which exceeds consensus estimates. Meanwhile, JMP Securities also increased its price target to $725, noting the potential of Axon’s AI Era Plan bundle and the growing demand for counter-drone solutions. Craig-Hallum downgraded Axon from Buy to Hold due to valuation concerns, despite anticipating strong fourth-quarter results and record bookings potentially surpassing $2 billion.
TD Cowen maintained a Buy rating with a $700 price target, expressing confidence in Axon’s growth following the termination of its partnership with Flock Safety, suggesting a strategic pivot towards its Fusus acquisition. Barclays (LON:BARC) maintained an Overweight rating, with a $585 target, focusing on Axon’s revenue projections and potential federal business impacts due to the Trump administration’s policies. Each of these analyses reflects varying perspectives on Axon’s current market position and future potential, offering investors insights into the company’s strategic maneuvers and financial expectations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.